Alpha Cognition Inc. cotiza a 8.80 USD y tiene una capitalización bursátil de $192M. En los últimos 12 meses ha facturado $15M con un margen de flujo de caja libre del -202.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical dev…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.32 | $-0.31 |
| Estimado | $-0.33 | $-0.39 | $-0.39 | $-0.35 |
| Sorpresa | — | — | +17.9% | +11.4% |
| Métrica | ACOG | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 94.1% | 57.0% | +37.1% |
| Operating Margin | -221.7% | -38.6% | -183.1% |
| Net Margin | -202.2% | -33.6% | -168.7% |
| FCF Margin | -202.3% | -13.9% | -188.4% |
| ROE | -33.1% | -40.4% | +7.3% |
| ROA | -25.9% | -32.0% | +6.1% |
| Current Ratio | 8.65 | 2.84 | +5.81 |
| Debt / Equity | — | 0.28 | — |